IL6 and type 2 diabetes mellitus: Further clinical trials revealed that pro-inflammatory markers, such as IL-6, high-sensitivity C-reactive protein (hs-CRP) and E-selectin, were also decreased by supplementation of PJ in T2D patients [89,101].